Skip to main content
Oxford University Hospitals NHS Foundation Trust

Alert Coronavirus / COVID-19

If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).

Please find information on our services and visiting restrictions in our COVID-19 section.

Patients and visitors must wear a face covering in our hospitals.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

European Prevention of Alzheimer's Dementia

Trial categories: Brain; Dementia

Sponsoring organisation: Innovative Medicines Initiative and University of Oxford

Better understanding dementia and how to prevent it

Changes in the brain, thought to be linked to Alzheimer's disease, can be seen decades before the first symptoms appear.

Recent studies suggest that early intervention and prevention might be the most effective way of fighting the disease.

The EPAD study aims to:

  1. improve understanding of the early aspects of Alzheimer's disease before dementia develops
  2. rapidly develop new treatments which can delay or prevent Alzheimer's dementia.

Participant inclusion criteria

  • Aged 50 or over
  • Have no dementia diagnosis
    • participants with mild cognitive impairment are welcome
    • carers or relatives of people with dementia are also welcome
  • Willing to consider taking part in clinical trials
  • Have a friend or relative who knows them well and is willing to be their study partner throughout the study

Participation involves:

Initial screening visits to Warneford Hospital for cognitive tasks, an MRI brain scan and research samples. Then a subsequent visit at 6 months, 1 year, 2 years, 3 years and 4 years.

If you are interested and would like more information, please contact: